Effect of gender and apolipoprotein E genotype on response to anticholinesterase therapy in Alzheimer's disease.

doi:10.1002/(sici)1099-1166(199809)13:9<625::aid-gps835>3.0.co;2-2

Back to search

Article

Effect of gender and apolipoprotein E genotype on response to anticholinesterase therapy in Alzheimer's disease.

International journal of geriatric psychiatry - 1 Sept 1998

MacGowan S H, Wilcock G K, Scott M

Abstract excerpt

BACKGROUND: Anticholinesterase therapies offer modest benefit to subgroups of AD sufferers. However, there has previously been no way of predicting which patients will respond to any of the drugs. OBJECTIVE: To discover if gender and/or apolipoprotein E genotype can be used as predictors of respo...

Topics

Alzheimer Disease
Apolipoproteins E
Cholinesterase Inhibitors
Double-Blind Method
Female
Galantamine
Genotype
Humans
Male
Sex Characteristics
Tacrine
Time Factors

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.